Reconstructing metastatic seeding patterns of human cancers.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 28139641)

Published in Nat Commun on January 31, 2017

Authors

Johannes G Reiter1, Alvin P Makohon-Moore2,3, Jeffrey M Gerold4, Ivana Bozic4,5, Krishnendu Chatterjee6, Christine A Iacobuzio-Donahue7, Bert Vogelstein8,9, Martin A Nowak4,5,10

Author Affiliations

1: IST Austria (Institute of Science and Technology Austria), Am Campus 1, Klosterneuburg 3400, Austria jreiter@ist.ac.at.
2: The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
3: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
4: Program for Evolutionary Dynamics, Harvard University, Cambridge, Massachusetts 02138, USA.
5: Department of Mathematics, Harvard University, Cambridge, Massachusetts 02138, USA.
6: IST (Institute of Science and Technology) Austria, Klosterneuburg 3400, Austria.
7: Department of Pathology, David Rubenstein Center for Pancreatic Cancer Research, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
8: The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
9: The Ludwig Center and Howard Hughes Medical Institute at The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
10: Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, Massachusetts 02138, USA.

Articles cited by this

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56

The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88

Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82

The clonal evolution of tumor cell populations. Science (1976) 24.39

Genetic instabilities in human cancers. Nature (1998) 22.76

Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38

The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43

The life history of 21 breast cancers. Cell (2012) 10.59

Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 10.52

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature (2012) 10.17

Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33

Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A (2008) 7.22

Emerging landscape of oncogenic signatures across human cancers. Nat Genet (2013) 6.48

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet (2014) 5.74

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (2014) 5.63

AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89

phangorn: phylogenetic analysis in R. Bioinformatics (2010) 4.57

Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A (2010) 4.47

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science (2014) 4.28

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood (2012) 3.63

The evolutionary history of lethal metastatic prostate cancer. Nature (2015) 3.59

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell (2012) 3.39

PyClone: statistical inference of clonal population structure in cancer. Nat Methods (2014) 3.08

Evolutionary dynamics of cancer in response to targeted combination therapy. Elife (2013) 2.76

Fast computation and applications of genome mappability. PLoS One (2012) 2.73

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell (2015) 2.57

Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nat Genet (2017) 2.42

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol (2013) 2.35

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet (2015) 2.29

Mutations driving CLL and their evolution in progression and relapse. Nature (2015) 2.06

The infinite sites model of genome evolution. Proc Natl Acad Sci U S A (2008) 1.89

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol (2014) 1.88

Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med (2015) 1.74

Using tumour phylogenetics to identify the roots of metastasis in humans. Nat Rev Clin Oncol (2015) 1.59

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov (2015) 1.51

Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36

Metastatic colonization by circulating tumour cells. Nature (2016) 1.31

Identification of neutral tumor evolution across cancer types. Nat Genet (2016) 1.25

TrAp: a tree approach for fingerprinting subclonal tumor composition. Nucleic Acids Res (2013) 1.23

BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies. Genome Biol (2015) 1.22

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med (2016) 1.22

Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nat Cell Biol (2014) 1.22

PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol (2015) 1.17

Fast and scalable inference of multi-sample cancer lineages. Genome Biol (2015) 1.13

Metastasis as an evolutionary process. Science (2016) 1.11

Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat Genet (2016) 1.10

Clonality inference in multiple tumor samples using phylogeny. Bioinformatics (2015) 1.05

Hypermutable DNA chronicles the evolution of human colon cancer. Proc Natl Acad Sci U S A (2014) 1.02

Growth rate of pancreatic adenocarcinoma: initial clinical experience. Pancreas (2001) 1.01

The mathematics of cancer: integrating quantitative models. Nat Rev Cancer (2015) 1.00

Reconstruction of clonal trees and tumor composition from multi-sample sequencing data. Bioinformatics (2015) 0.96

Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discov (2015) 0.94

SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing. PLoS Comput Biol (2015) 0.94

Inferring mutational timing and reconstructing tumour evolutionary histories. Biochim Biophys Acta (2015) 0.90

The effect of one additional driver mutation on tumor progression. Evol Appl (2012) 0.90

Inference of tumor phylogenies with improved somatic mutation discovery. J Comput Biol (2013) 0.89

Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. PLoS Comput Biol (2016) 0.86

Inferring the Origin of Metastases from Cancer Phylogenies. Cancer Res (2015) 0.81

Better methods for solving parsimony and compatibility. J Comput Biol (1998) 0.79